Network Pharmacology and Apoptosis Insights: Chrysanthemum i
2026-05-12
Integrated Network Pharmacology and Apoptosis Analysis of Chrysanthemum indicum L. in Glioma Research
Study Background and Research Question
Gliomas are among the most aggressive forms of primary brain tumors, characterized by rapid proliferation, high migratory capacity, and resistance to standard chemotherapeutic regimens. The search for novel therapeutic agents has increasingly focused on natural products with recognized historical use and diverse bioactive components. Chrysanthemum indicum L., traditionally used in Chinese medicine for its anti-inflammatory and anticancer effects, is a principal component of the clinically utilized Jiawei Juming Decoction (JWJM) for glioma management. However, direct evidence supporting the anti-glioma efficacy and underlying mechanisms of Chrysanthemum indicum L. extract (CIE) remains sparse. This study addresses the central research question: can CIE inhibit glioma progression, and if so, through which molecular mechanisms does it exert its effects? (paper)Key Innovation from the Reference Study
The innovation of this work lies in its integrative approach, combining network pharmacology, molecular docking, and experimental biology to systematically dissect the anti-glioma actions of CIE. Notably, the study utilizes computational target prediction and interaction mapping, followed by empirical validation, to bridge the gap between in silico predictions and biological outcomes. This methodology enables the identification of not only key bioactive compounds within the extract but also their direct molecular targets implicated in glioma pathogenesis (paper).Methods and Experimental Design Insights
The study employed a multi-tiered research strategy:- Compound and Target Identification: Active constituents of CIE were retrieved from the TCMSP and ETCM databases. Glioma-associated targets were sourced from GeneCards and DisGeNET, with overlaps identified via Venn analysis.
- Protein-Protein Interaction and Pathway Analysis: STRING database enabled PPI network construction. Key targets were prioritized through centrality and network topology measures. GO and KEGG enrichment analyses highlighted biological processes and pathways.
- Network Construction: Cytoscape software synthesized compound-target-pathway relationships, identifying core compounds and their mechanistic relevance.
- Molecular Docking: The binding affinities between major CIE compounds (notably kaempferol, naringenin, and luteolin) and pivotal targets, especially androgen receptor (AR), were quantified via docking simulations.
- Experimental Validation: In vitro assays using C6 glioma cells and in vivo models assessed the effects on proliferation, migration, and apoptosis. Apoptosis was measured via established laboratory methods suitable for DNA fragmentation detection in apoptosis (paper).
Protocol Parameters
- apoptosis assay | TUNEL-based, TdT enzyme catalysis | tissue sections and cultured glioma cells | Detects DNA fragmentation, the hallmark of apoptosis, using biotin-dUTP incorporation and chromogenic DAB detection | workflow_recommendation
- sample type | paraffin-embedded/frozen tissue, adherent/suspension cells | applicable to both in vivo and in vitro models | Enables cross-validation of apoptosis across experimental systems | workflow_recommendation
- apoptotic index quantification | % apoptotic cells per field | in vitro and in vivo glioma models | Measures efficacy of CIE in inducing programmed cell death | paper
- positive control | DNase I-treated samples | ensures assay specificity | Confirms the method's capacity to detect DNA fragmentation | product_spec
Core Findings and Why They Matter
The combined computational and experimental approach yielded several critical insights:- Bioactive Compounds and Targets: Twenty-three active compounds were identified in CIE, interacting with 130 major targets. Through network analysis, nine key targets were highlighted, including ESR1, SIRT1, HSP90AA1, PTGS2, RELA, AR, NOS3, DNMT1, and GSK3B (paper).
- Pathway Enrichment: GO and KEGG analyses revealed that these targets are concentrated in pathways associated with cancer progression and apoptosis. The androgen receptor (AR) emerged as a critical node for glioma cell survival and proliferation.
- Molecular Docking Evidence: Flavonoid compounds such as kaempferol, naringenin, and luteolin demonstrated strong binding affinities to AR, suggesting a plausible route for CIE-mediated AR modulation.
- Empirical Validation: CIE significantly inhibited both proliferation and migration of C6 glioma cells and, importantly, increased apoptotic rates as evidenced by DNA fragmentation assays. These effects were confirmed in both in vitro and in vivo settings (paper).
Comparison with Existing Internal Articles
Recent internal resources, such as "Optimizing TUNEL Apoptosis Detection Kit Workflows in Research" (internal_article), provide practical guidance on maximizing sensitivity and troubleshooting in DNA fragmentation detection, directly aligning with the apoptosis assessment protocols used in the reference study. Similarly, "TUNEL Apoptosis Detection Kit (DAB): Precision DNA Fragmentation Detection" (internal_article) details the mechanistic foundation and interpretive reliability of TUNEL assays, reinforcing the methodological choices in the present research. These resources complement the reference study by offering workflow enhancements, protocol refinement, and interpretive rigor to apoptosis detection in both tissue and cellular contexts.Limitations and Transferability
While the study robustly links CIE-induced apoptosis to AR-mediated pathways in glioma, several limitations merit consideration:- Bioactive compound profiles may vary with extraction methods, plant growth conditions, and batch variability, affecting reproducibility across laboratories (workflow_recommendation).
- The study predominantly utilizes rodent-derived C6 glioma cells; human glioma heterogeneity and microenvironmental factors may limit direct clinical translation (paper).
- While apoptosis was rigorously measured, other forms of cell death (e.g., necroptosis, autophagy) were not excluded as contributors to the observed effects.